Alphabet Inc.’s Google DeepMind today introduced AlphaGenome, a new artificial intelligence tool that can comprehensively predict how mutations or variants in human DNA sequences impact gene ...

The discovery, led by researchers at Dana-Farber, could pave the way for interventions to reduce the risk of blood cancers among people with sickle-cell disease. A large-scale genomic analysis, led by ...

Sickle cell disease is a genetic disease caused by a point mutation, where the 6th residue of β chains of hemoglobin (Hb) is replaced by valine. In an oxygen-scarce environment, the mutated Hb, sickle ...

Over the past decade, non-viral DNA template delivery has been used with engineered nucleases to target single-stranded DNA sequences in hematopoietic stem and progenitor cells. While effective for ...

New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease, a genetic blood disorder with few curative options. After research conducted as ...

Sickle Cell Disease (SCD) remains a silent scourge—a genetic disorder passed down with the heavy hand of biology but sustained through societal neglect. In Nigeria, the burden is not only colossal—it ...

Researchers have discovered new regions of the human genome particularly vulnerable to mutations. These altered stretches of DNA can be passed down to future generations and are important for how we ...

Sickle cell disease is the scourge of a person’s red blood cells. The inherited blood disorder, which disproportionately affects people in sub-Saharan Africa and India, can cause unbearable pain ...

Aligning with the aim of eradicating sickle cell disease which is largely prevalent among the tribal population, India on Wednesday launched the first indigenous CRISPR-based gene therapy. The ...